Dong-E-E-Jiao Co., Ltd. Class A 000423

SZSE · China · Health Technology

CNY 45.95+0.71 (+1.57%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

Dong-E-E-Jiao Co., Ltd. Class A 000423

SZSE · China · Health Technology

CNY 45.95+0.71 (+1.57%)

Market closed· Sep 30, 2026, 7:04 AM UTC· CNY · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-20.09% · 6MFull-screen chart

Open CNY 45.26High CNY 46.12Low CNY 45.26Close CNY 45.95Volume 4.34M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: CNY 45.24
Day range: CNY 45.26 – CNY 46.12
52-week range: CNY 42.88 – CNY 58.36
Volume: 4.34M
Market cap: CNY 28.94B
P/E (TTM): 16.6
Dividend yield (annualized): 6.05%
Next earnings date: 2026-11-04
Avg. volume (1Y): 6.57M

Performance

1 week

-0.61%

1 month

-4.77%

3 months

+2.72%

6 months

-14.83%

Year to date

-3.51%

1 year

+0.60%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Other
Country: China
Exchange: SZSE
Shares outstanding: 635.68M
Employees: 4,345
ISIN: CNE0000006Y9
Beta: 0.70

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceApr 12, 2026

AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry

Hong Kong, SAR--(Newsfile Corp. - April 12, 2026) - AilsynBio, an AI-driven drug discovery company, held an Innovative Project Cooperation Agreement Signing Ceremony today at the Hong Kong Science Park, announcing a project cooperation agreement with Dong-E-E-Jiao Co., Ltd. (SZSE: 000423). This partnership marks a profound cross-sector integration of Artificial Intelligence (AI) and traditional medicine, aiming to empower biopharmaceutical innovation through technological means.The ceremony...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.